Avantor (NYSE:AVTR) Director Gregory Lucier Acquires 50,000 Shares

Avantor, Inc. (NYSE:AVTR) Director Gregory Lucier purchased 50,000 shares of the firm’s stock in a transaction dated Thursday, February 19th. The stock was acquired at an average price of $9.16 per share, for a total transaction of $458,000.00. Following the purchase, the director owned 50,000 shares in the company, valued at approximately $458,000. The trade was a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Avantor Price Performance

Shares of AVTR stock opened at $8.89 on Tuesday. The business has a fifty day simple moving average of $11.14 and a 200 day simple moving average of $12.09. The company has a market cap of $6.06 billion, a P/E ratio of -11.40, a P/E/G ratio of 3.56 and a beta of 0.94. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. Avantor, Inc. has a twelve month low of $8.83 and a twelve month high of $18.02.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.01. The company had revenue of $1.66 billion for the quarter, compared to analyst estimates of $1.64 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The firm’s revenue was down 1.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, sell-side analysts forecast that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Institutional Trading of Avantor

A number of hedge funds and other institutional investors have recently bought and sold shares of AVTR. EverSource Wealth Advisors LLC increased its holdings in Avantor by 119.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares in the last quarter. Private Trust Co. NA raised its stake in shares of Avantor by 46.2% during the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after purchasing an additional 875 shares during the period. Strategic Wealth Investment Group LLC purchased a new position in shares of Avantor in the 2nd quarter worth about $32,000. Los Angeles Capital Management LLC bought a new position in Avantor during the fourth quarter valued at about $32,000. Finally, Osaic Holdings Inc. increased its holdings in Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Bank of America cut Avantor from a “buy” rating to a “neutral” rating and set a $13.00 target price for the company. in a report on Monday, December 15th. Evercore set a $10.00 target price on shares of Avantor in a research report on Wednesday, February 11th. Zacks Research lowered shares of Avantor from a “hold” rating to a “strong sell” rating in a report on Friday, February 13th. UBS Group reaffirmed a “neutral” rating and set a $10.50 price target on shares of Avantor in a research note on Thursday, February 12th. Finally, Jefferies Financial Group reaffirmed an “underperform” rating and set a $8.00 target price on shares of Avantor in a report on Thursday, February 12th. Three analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $11.83.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.